SCHEMBL6251001

SCHEMBL6251001

O=C(O)c1cnc2ccccc2[n+]1[O-]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.43
HPGD P15428 3/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MGAM O43451 2/20 0.41
HCAR2 Q8TDS4 1/20 0.38
MAPT P10636 4/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
RAB9A P51151 2/20 0.35
NPC1 O15118 1/20 0.35
GAA P10253 1/20 0.34
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
KEAP1 Q14145 1/20 0.33
NFE2L2 Q16236 1/20 0.33
MAPK1 P28482 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4899652 0.71 BCL2 (0.37) ALDH1A1HPGDMAPTSMN1; SMN2KDM4E
SCHEMBL13503079 0.71 CRHBP (0.37) ALDH1A1HPGDHSD17B10MAPTSMN1; SMN2
SCHEMBL11710268 0.71 CRHBP (0.37) ALDH1A1SMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL864536 0.71 CRHBP (0.37) ALDH1A1KDM4EMEN1KMT2AGAA
SCHEMBL27913228 0.71 CRHBP (0.40) ALDH1A1HPGDHCAR2MAPTSMN1; SMN2
SCHEMBL28159300 0.70 ERN1 (0.41) ALDH1A1HPGDALOX15HSD17B10MAPT
SCHEMBL6806663 0.69 LMNA (0.42) ALDH1A1HPGDALOX15HSD17B10HCAR2
SCHEMBL3869264 0.69 ATM (0.47) ALDH1A1HPGDALOX15HSD17B10MGAM
SCHEMBL3887568 0.67 CRHBP (0.34) ALDH1A1KDM4EGAACRHBPCRHR2
SCHEMBL10865681 0.66 ALDH1A1 (0.58) ALDH1A1HPGDALOX15MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103242250-A Preparation method of 2-quinoxaline methylene hydrazino cyanoacetic acid-N1-oxide UNIV CHINA AGRICULTURAL 2013-08-14 CN claimed
EP-1558587-A1 HETEROARYL-HEXANOIC ACID AMIDE DERIVATIVES AS IMMUNOMODULATORY AGENTS Pfizer Products Inc. (US) 2005-08-03 EP claimed
US-20040097554-A1 Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents PFIZER INC 2004-05-20 US claimed
WO-2004039787-A1 HETEROARYL-HEXANOIC ACID AMIDE DERIVATIVES AS IMMUNOMODULATORY AGENTS PFIZER PRODUCTS INC. (US) 2004-05-13 WO claimed
CN-103242250-A Preparation method of 2-quinoxaline methylene hydrazino cyanoacetic acid-N1-oxide UNIV CHINA AGRICULTURAL 2013-08-14 CN disclosed
EP-1558587-A1 HETEROARYL-HEXANOIC ACID AMIDE DERIVATIVES AS IMMUNOMODULATORY AGENTS Pfizer Products Inc. (US) 2005-08-03 EP disclosed
US-20040097554-A1 Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents PFIZER INC 2004-05-20 US disclosed
WO-2004039787-A1 HETEROARYL-HEXANOIC ACID AMIDE DERIVATIVES AS IMMUNOMODULATORY AGENTS PFIZER PRODUCTS INC. (US) 2004-05-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097554-A1 Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents CCR1, HCAR1, CCR3 ALDH1A1 303/4885HPGD 1924/4885ALOX15 356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.